Yahoo
OTC Markets OTCPK - Delayed Quote USD

Banyan Corp. (BNYN)

0.0002 0.0000 (0.00%)
At close: October 30 at 4:00:00 PM EDT
Chart Range Bar
Loading chart for BNYN
  • Previous Close 0.0002
  • Open 0.0000
  • Bid --
  • Ask --
  • Day's Range 0.0000 - 0.0000
  • 52 Week Range 0.0000 - 0.0002
  • Volume 5
  • Avg. Volume 0
  • Market Cap (intraday) 4,544
  • Beta (5Y Monthly) 150.04
  • PE Ratio (TTM) 0.00
  • EPS (TTM) 0.0600
  • Earnings Date --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Banyan Corp., through its subsidiaries, engages in the franchising of chiropractic clinics in North America. It provides practice development training and assistance to chiropractors, as well as offers franchise support and related services to franchisees and licensees. The company also offers diagnostic testing services. Banyan Corporation provides nerve conduction velocity (NCV) testing to patients through health care professionals, such as doctors and chiropractors. The NCV testing measures the transmission of nerve impulses through the body, identifies problems in the nervous system, and enables to substantiate the cost of treatment to patients and their insurers. In addition, it manufactures and markets the VT3000, a nerve testing system for the diagnosis of neuropathies, which are diseases of the peripheral nerves and parts of the spine, as well as nerve irritation and other damage to the nervous system of a patient. The company was founded in 1978 and is based in Beverly Hills, California.

20

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

BNYN
0.00%
S&P 500 (^GSPC)
10.73%

1-Year Return

BNYN
0.00%
S&P 500 (^GSPC)
11.11%

3-Year Return

BNYN
90.00%
S&P 500 (^GSPC)
81.91%

5-Year Return

BNYN
90.00%
S&P 500 (^GSPC)
64.59%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -114.99%

  • Return on Assets (ttm)

    -25.21%

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    3.48M

  • Net Income Avi to Common (ttm)

    -4M

  • Diluted EPS (ttm)

    0.0600

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    66.58k

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    1.86M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: